Welcome to our dedicated page for Avient SEC filings (Ticker: AVNT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Avient’s color additives tint everything from recyclable food packaging to advanced medical devices, yet the business details sit deep inside dense SEC documents. If you’ve ever hunted for segment margins on specialty engineered materials or tried to confirm executive stock sales before resin price moves, you know why investors ask, "Avient SEC filings explained simply."
Stock Titan pulls every release the instant it hits EDGAR—whether it’s an Avient quarterly earnings report 10-Q filing that breaks down raw-material costs, an Avient annual report 10-K simplified that maps global demand for Color, Additives & Inks, or an Avient 8-K material events explained alert on unexpected supply-chain updates. Our AI-powered summaries translate accounting language into plain English, highlight segment revenue shifts, and flag sustainability commitments. Need to monitor Avient insider trading Form 4 transactions? Real-time dashboards track every Avient Form 4 insider transactions real-time entry so you can spot patterns before they surface in headlines.
Use the platform to:
- Compare quarter-over-quarter resin price impact with one-click Avient earnings report filing analysis
- Review Avient proxy statement executive compensation without paging through PDFs
- Set alerts for Avient executive stock transactions Form 4 and other filings
- Save hours by understanding Avient SEC documents with AI—from cash-flow tables to ESG footnotes
All filing types, one place, always current. Complex polymers may color the world, but your research doesn’t have to be complicated.
Avient Corporation (AVNT) Form 4 filing: Director Patricia Verduin disclosed the acquisition of 1,187 shares of Avient common stock on 06/30/2025. The transaction is coded “A” (acquired) with a stated price of $0, suggesting a grant or similar non-cash transaction. Following this filing, Verduin now directly owns 23,866 shares of AVNT. No sales or derivative security transactions were reported, and there were no indications of 10b5-1 plan usage. The Form was signed on 07/02/2025 by attorney-in-fact Robert K. James.